AIO APEX

Blog

Latest articles on AI, technology, and software development.

AI-designed drugs are closing in on their first regulatory approval
Science & Research

AI-designed drugs are closing in on their first regulatory approval

More than 173 AI-originated drug programs are now in clinical development, up from 67 in 2023, with Insilico Medicine's Phase III fibrosis candidate leading a field analysts expect to see its first approval within two years.

ai-drug-discoverybiotech